Stay updated on VK2809 Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the VK2809 Efficacy in NASH Clinical Trial page.

Latest updates to the VK2809 Efficacy in NASH Clinical Trial page
- Check4 days agoChange DetectedThe page now includes additional related-topic links to Non-alcoholic fatty liver disease and MedlinePlus Genetics.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded a comprehensive Locations section with state- and country-level site entries (e.g., Alabama, California, Guerrero, Nuevo León) and removed individual location groupings (e.g., Alabama Locations, Guerrero Locations).SummaryDifference2%

- Check18 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics under the Related Topics section.SummaryDifference0.1%

- Check25 days agoChange DetectedRelated topics such as 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the study page for broader context.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows a new Revision: v3.3.2 and removes related-topic tags including 'Non-alcoholic Fatty Liver Disease' and 'MedlinePlus Genetics' as well as the older 'Revision: v3.2.0' tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to VK2809 Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VK2809 Efficacy in NASH Clinical Trial page.